Replies to post #162313 on Biotech Values

[DewDiligence]

Very timely regulatory approval for MON insofar as it comes just in time for the 2013 growing season in Brazil and Argentina. Both countries had already approved MON’s Intacta soybeans for planting (#msg-55517002), and China’s approval for importation was the last remaining roadblock to commercialization.

Intacta, MON’s first-ever product developed specifically for a non-US country, will surely become one of MON’s major growth drivers during the next 5-10 years.

[DewDiligence]

Macquarie upgrades MON to Outperform, seeing an attractive entry point for investors.

Last week—following the selloff predicated by the non-commercial GM-wheat found in Oregon—would’ve been an even better entry point :- )

[DewDiligence]

China’s approval of MON’s Intacta brand soybeans has been formally announced:

#msg-89092973

As noted in #msg-88839612, Intacta is MON’s first-ever product developed specifically for a non-US country (Brazil and Argentina), and it will surely become one of MON’s major growth drivers during the next 5-10 years. China’s approval for importation comes just in time for the 2013-2014 growing season in the Southern Hemisphere.

For background info on Intacta, please see #msg-55517002.